Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Trastuzumab
Hormone Receptor-Positive Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (66)
Trastuzumab
Invasive Breast Carcinoma
Massachusetts General HospitalP3BB (66)
Tretinoin
Leukemia
SDK Therapeutics, Inc.P3BB (66)
Trontinemab
Alzheimer Disease
Hoffmann-La RocheP3BB (66)
Veliparib
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)P3BB (66)
Vemurafenib
Melanoma
Cancer Research UKP3BB (66)
Venetoclax
Disease Related To Hematopoietic Stem Cell Transplant
The First Affiliated Hospital of Soochow UniversityP3BB (66)
Venetoclax
Myeloid Neoplasm
First Affiliated Hospital of Zhejiang UniversityP3BB (66)
Vibostolimab
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP3BB (66)
(+)-Vincristine
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkP3BB (66)
Vincristine Sulfate
Primary Mediastinal Large B-Cell Lymphoma
National Research Center for Hematology, RussiaP3BB (66)
Vincristine Sulfate
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP3BB (66)
Vincristine Sulfate
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Vincristine Sulfate
Lymphoblastic Lymphoma
City of Hope Medical CenterP3BB (66)
Vincristine Sulfate
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Vincristine Sulfate
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3BB (66)
Vinorelbine Ditartrate
Lung Large Cell Carcinoma
AIO-Studien-gGmbHP3BB (66)
Vosaroxin
Acute Myeloid Leukemia
University of UlmP3BB (66)
Zanubrutinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP3BB (66)
Zanubrutinib
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP3BB (66)
Zanubrutinib
Marginal Zone Lymphoma
Zhengzhou UniversityP3BB (66)
Zanubrutinib
Splenic Marginal Zone Lymphoma
SWOG Cancer Research NetworkP3BB (66)
Adriamycin
Primary Effusion Lymphoma
National Cancer Institute (NCI)P2BB (66)
Axicabtagene Ciloleucel
Primary Mediastinal Large B-Cell Lymphoma
AIDS Malignancy ConsortiumP2BB (66)
Azacitidine
Acute Myeloid Leukemia With 11q23 Abnormalities
Northwestern UniversityP2BB (66)
Showing 2351 to 2375 of 42,301 assets
PreviousPage 95 of 1693Next